Announcements

Search
  • PCPC
    • Jul 31, 2019
    • 1 min read

Developing the Next Generation PD-L1 Assays Using Precision Mass Spectrometry

The McGill node has received funding from the Genome Canada Genomic Applications Partnership Program (GAPP) to  develop PD-L1 Mass Spectrometry (MS)-based assays for use in immune-oncology.


View Full Article

22 views

Recent Posts

See All

UVic upgrades Agilent QqQ's

In partnership with Agilent, we have upgraded 2 of our 6490 triple quadrupole mass spectrometers the the latest 6495b platforms. These newer instruments enable greater sensitivity and the ability to q

2

Our Funding Partners

genome_canada_logo.png
CFI_WHT.png
Genome_BC_logo.png

© Pan-Canadian Proteomic Centre 2020